Pacheco e Silva A, Landi de Almedia A M
Angiology. 1981 Oct;32(10):728-32. doi: 10.1177/000331978103201010.
In this paper a comparison was established from the clinical, neurological, psychological, and laboratory viewpoints, between the effects on the cental nervous system of a vasodilating medication, cinnarizine, currently accepted as effective, and buflomedil, a medicine recently introduced, which has shown good promise in the treatment of peripheral vascular diseases. During a 180-day period, 37 patients suffering from vascular cerebral insufficiency, aged between 43 and 86 years, were treated. The patients were randomized into two groups, each group receiving one of the treatments in a double-blind study. All patients were periodically administered clinical and neurological tests, and the Benton Test for visuo retention through which the intellectual level, recent memory, and visuo-motor coordination were examined. In addition, the patients were given a series of laboratory toxicity tests to ascertain the safety of the treatment. On completion of the study all data submitted to a statistical analysis. After studying the results, the authors reached the conclusion that both treatments were beneficial; when corresponding doses were used, buflomedil showed better results by improving the reasoning and the remote memory, and in the Benton test, better results in improving visuo-motor coordination were demonstrated by statistical analysis. Laboratory tests did not reveal any changes except in the serum cholesterol level, which decreased significantly in those patients who took buflomedil.
本文从临床、神经学、心理学和实验室角度,对目前被认为有效的血管扩张药物桂利嗪与最近引入的丁咯地尔(在治疗外周血管疾病方面显示出良好前景)对中枢神经系统的影响进行了比较。在180天的时间里,对37名年龄在43至86岁之间的血管性脑供血不足患者进行了治疗。患者被随机分为两组,在双盲研究中每组接受一种治疗。所有患者定期接受临床和神经学测试,以及用于检查智力水平、近期记忆和视觉运动协调性的本顿视觉保持测试。此外,还对患者进行了一系列实验室毒性测试,以确定治疗的安全性。研究结束后,所有数据都进行了统计分析。在研究结果后,作者得出结论,两种治疗方法都有益;当使用相应剂量时,丁咯地尔通过改善推理和远期记忆显示出更好的效果,并且在本顿测试中,通过统计分析表明在改善视觉运动协调性方面有更好的效果。实验室测试除了血清胆固醇水平外未发现任何变化,服用丁咯地尔的患者血清胆固醇水平显著下降。